BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4206221)

  • 21. Hepatic involvement in the course of acquired toxoplasmosis.
    Kouba K; Jíra J; Zítová D
    Acta Paediatr Scand; 1971 Jul; 60(4):482-7. PubMed ID: 5104865
    [No Abstract]   [Full Text] [Related]  

  • 22. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.
    McLeod R; Boyer K; Karrison T; Kasza K; Swisher C; Roizen N; Jalbrzikowski J; Remington J; Heydemann P; Noble AG; Mets M; Holfels E; Withers S; Latkany P; Meier P;
    Clin Infect Dis; 2006 May; 42(10):1383-94. PubMed ID: 16619149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In utero treatment of congenital toxoplasmosis with a pyrimethamine-sulfadiazine combination].
    Couvreur J
    Presse Med; 1991 Jun; 20(24):1136. PubMed ID: 1830148
    [No Abstract]   [Full Text] [Related]  

  • 24. [Toxoplasmosis].
    Bonardi R
    Minerva Med; 1980 Feb; 71(4):297-300. PubMed ID: 6986589
    [No Abstract]   [Full Text] [Related]  

  • 25. [Toxoplasmosis: modern diagnostic and therapeutic management (Part II)].
    Shimoni Z; Flatau E; Raz R
    Harefuah; 1988 Dec; 115(12):390-3. PubMed ID: 3071510
    [No Abstract]   [Full Text] [Related]  

  • 26. Simultaneous determination of pyrimethamine, sulfadiazine and N-acetyl-sulfadiazine in plasma for monitoring infants in treatment of congenital toxoplasmosis.
    Johannessen JK; Christiansen I; Schmidt DR; Petersen E; Hansen SH
    J Pharm Biomed Anal; 2005 Jan; 36(5):1093-8. PubMed ID: 15620537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The significance of the results of serological tests carried out during pregnancy for the prevention and diagnosis of congenital toxoplasmosis].
    Lässker G; Degen R; Keller J
    Z Kinderheilkd; 1969; 105(2):132-41. PubMed ID: 5813227
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of ultra-long-acting sulphonamide, sulphamethoxypyrazine (Longum-Kelfizina) on the proliferative phase of replication of Toxoplasma gondii in NMRI mice. Contribution to experimental chemotherapy of toxoplasmosis].
    Werner H; Dannemann R; Egger I
    Zentralbl Bakteriol Orig A; 1972 Oct; 222(1):126-41. PubMed ID: 4145146
    [No Abstract]   [Full Text] [Related]  

  • 29. [Opportunistic Toxoplasma gondii infections].
    Reinert P; Bernaudin F
    Arch Fr Pediatr; 1985 Dec; 42 Suppl 2():949-51. PubMed ID: 3833107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Toxoplasmosis].
    Presse Med (1893); 1969 Mar; 77(16):595. PubMed ID: 4977375
    [No Abstract]   [Full Text] [Related]  

  • 31. [Epidemiology of toxoplasmosis].
    Couvreur J; Desmonts G
    Rev Med Suisse Romande; 1974 Apr; 94(4):261-9. PubMed ID: 4826389
    [No Abstract]   [Full Text] [Related]  

  • 32. [Sulfadiazine, pyrimethamine, spiramycin and folic acid in congenital toxoplasmosis].
    Sedan J
    Mars Med; 1967; 104(4):343-5. PubMed ID: 5621539
    [No Abstract]   [Full Text] [Related]  

  • 33. Symptoms, transmission, prevention and treatment of toxoplasmosis.
    Markus MB
    S Afr Med J; 1973 Sep; 47(35):1588-90. PubMed ID: 4734032
    [No Abstract]   [Full Text] [Related]  

  • 34. [Significance of post-partum diagnosis of congenital toxoplasmosis primary maternal infection at the end of the pregnancy].
    Wirden M; Botterel F; Romand S; Ithier G; Bourée P
    J Gynecol Obstet Biol Reprod (Paris); 1999 Oct; 28(6):566-7. PubMed ID: 10598352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Aqueduct stenosis and toxoplasmosis].
    den Hartog Jager WA
    Ned Tijdschr Geneeskd; 1972 Apr; 116(15):589-91. PubMed ID: 5045335
    [No Abstract]   [Full Text] [Related]  

  • 36. [Letter: Treatment of toxoplasmosis].
    Thibault P
    Nouv Presse Med; 1973 Nov; 2(39):2601. PubMed ID: 4793316
    [No Abstract]   [Full Text] [Related]  

  • 37. Longitudinal study of new eye lesions in treated congenital toxoplasmosis.
    Phan L; Kasza K; Jalbrzikowski J; Noble AG; Latkany P; Kuo A; Mieler W; Meyers S; Rabiah P; Boyer K; Swisher C; Mets M; Roizen N; Cezar S; Remington J; Meier P; McLeod R;
    Ophthalmology; 2008 Mar; 115(3):553-559.e8. PubMed ID: 17825418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Research on congenital toxoplasmosis.
    Panaitescu D; Steriu D; Stefănoiu V; Pop M
    Roum Arch Microbiol Immunol; 1995; 54(4):313-24. PubMed ID: 8993124
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of toxoplasmosis. present knowledge and problems (author's transl)].
    Russo M; Galanti B; Nardiello S
    Ann Sclavo; 1980; 22(6):877-88. PubMed ID: 7294907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of toxoplasmosis acquired during pregnancy with spiramycin].
    Couvreur J; Desmonts C
    Zentralbl Gynakol; 1983; 105(17):1104-7. PubMed ID: 6650001
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.